A pill version of Novo Nordisk A/S’s Ozempic failed to slow the progression of Alzheimer’s disease in a pair of high-risk ...
Stocktwits on MSN
Novo Nordisk Stock Tumbles: HSBC Downgrades After ‘Lottery Ticket’ Alzheimer’s Bet Fails, But Retail Traders Call Selloff ‘Ridiculous’
HSBC cut Novo Nordisk to ‘Hold’ after its EVOKE Alzheimer’s trials showed no slowing of disease progression versus placebo.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback